Effects of finerenone in persons with
CKD
and
T2D
are independent of
HbA1c
at baseline,
HbA1c
variability, diabetes duration and insulin use at baseline
Effects of finerenone in persons with
CKD
and
T2D
are independent of
HbA1c
at baseline,
HbA1c
variability, diabetes duration and insulin use at baseline
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now